Bibby MC - Search Results

1

Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculature.

Shnyder SD, Hasan J, Cooper PA, Pilarinou E, Jubb E, Jayson GC, Bibby MC. Shnyder SD, et al. Among authors: bibby mc. Anticancer Res. 2005 May-Jun;25(3B):1889-94. Anticancer Res. 2005. PMID: 16158922 Free article.

2

Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.

Holwell SE, Cooper PA, Grosios K, Lippert JW 3rd, Pettit GR, Shnyder SD, Bibby MC. Holwell SE, et al. Among authors: bibby mc. Anticancer Res. 2002 Mar-Apr;22(2A):707-11. Anticancer Res. 2002. PMID: 12017147

3

Combretastatin A-1 phosphate potentiates the antitumour activity of cisplatin in a murine adenocarcinoma model.

Shnyder SD, Cooper PA, Pettit GR, Lippert JW 3rd, Bibby MC. Shnyder SD, et al. Among authors: bibby mc. Anticancer Res. 2003 Mar-Apr;23(2B):1619-23. Anticancer Res. 2003. PMID: 12820431

4

Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.

Shnyder SD, Cooper PA, Gyselinck N, Hill BT, Double JA, Bibby MC. Shnyder SD, et al. Among authors: bibby mc. Anticancer Res. 2003 Nov-Dec;23(6C):4815-20. Anticancer Res. 2003. PMID: 14981930

5

Reducing the cost of screening novel agents using the hollow fibre assay.

Shnyder SD, Cooper PA, Scally AJ, Bibby MC. Shnyder SD, et al. Among authors: bibby mc. Anticancer Res. 2006 May-Jun;26(3A):2049-52. Anticancer Res. 2006. PMID: 16827143 Free article.

6

Use of the hollow fiber assay for the evaluation of DNA damaging agents.

Veiga JP, Cooper PA, Pors K, Patterson LH, Bibby MC, Shnyder SD. Veiga JP, et al. Among authors: bibby mc. J Pharmacol Toxicol Methods. 2011 Nov-Dec;64(3):226-32. doi: 10.1016/j.vascn.2011.04.006. Epub 2011 Apr 30. J Pharmacol Toxicol Methods. 2011. PMID: 21569858

7

Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programs.

Phillips RM, Pearce J, Loadman PM, Bibby MC, Cooper PA, Swaine DJ, Double JA. Phillips RM, et al. Among authors: bibby mc. Cancer Res. 1998 Dec 1;58(23):5263-6. Cancer Res. 1998. PMID: 9850044

8

Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.

Holwell SE, Cooper PA, Thompson MJ, Pettit GR, Lippert LW 3rd, Martin SW, Bibby MC. Holwell SE, et al. Among authors: bibby mc. Anticancer Res. 2002 Nov-Dec;22(6C):3933-40. Anticancer Res. 2002. PMID: 12553015

9

Quantitative angiogenesis assays in vivo--a review.

Hasan J, Shnyder SD, Bibby M, Double JA, Bicknel R, Jayson GC. Hasan J, et al. Angiogenesis. 2004;7(1):1-16. doi: 10.1023/B:AGEN.0000037338.51851.d1. Angiogenesis. 2004. PMID: 15302991 Review.

10

Heparin octasaccharides inhibit angiogenesis in vivo.

Hasan J, Shnyder SD, Clamp AR, McGown AT, Bicknell R, Presta M, Bibby M, Double J, Craig S, Leeming D, Stevenson K, Gallagher JT, Jayson GC. Hasan J, et al. Clin Cancer Res. 2005 Nov 15;11(22):8172-9. doi: 10.1158/1078-0432.CCR-05-0452. Clin Cancer Res. 2005. PMID: 16299249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page